Development and Clinical Utility of a 21-Gene Recurrence Score Prognostic Assay in Patients with Early Breast Cancer Treated with Tamoxifen
Author:
Affiliation:
1. Division of Pathology, National Surgical Adjuvant Breast and Bowel Project, Pittsburgh, Pennsylvania, USA
Abstract
Funder
National Cancer Institute
Publisher
Oxford University Press (OUP)
Subject
Cancer Research,Oncology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-6-631
Reference17 articles.
1. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer;Paik;N Engl J Med,2004
2. NCCN Practice Guidelines for Breast Cancer;Carlson;Oncology (Williston Park),2000
3. Meeting highlights: Updated international expert consensus on the primary therapy of early breast cancer;Goldhirsch;J Clin Oncol,2003
4. Analysis of chemical modification of RNA from formalin-fixed samples and optimization of molecular biology applications for such samples;Masuda;Nucleic Acids Res,1999
5. Measurement of gene expression in archival paraffin-embedded tissues: Development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay;Cronin;Am J Pathol,2004
Cited by 156 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Network Pharmacology and Systems Biology in Drug Discovery;Interdisciplinary Biotechnological Advances;2023
2. Exploring the effects of genomic testing on fear of cancer recurrence among breast cancer survivors;Psycho-Oncology;2021-04-02
3. Luminal A breast cancer resistance mechanisms and emerging treatments;Biological Mechanisms and the Advancing Approaches to Overcoming Cancer Drug Resistance;2021
4. Racial and ethnic disparities in 21-gene recurrence scores, chemotherapy, and survival among women with hormone receptor-positive, node-negative breast cancer;Breast Cancer Research and Treatment;2020-09-14
5. Oncology Scan: Radiation Biology and Genomic Predictors of Response;International Journal of Radiation Oncology*Biology*Physics;2020-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3